共 139 条
- [1] O'Shea A(2019)Pelvic lymph nodes and pathways of disease spread in male pelvic malignancies Abdom Radiol (NY) 65 554-562
- [2] Kilcoyne A(2014)Predicting survival of patients with node-positive prostate cancer following multimodal treatment Eur Urol 53 118-125
- [3] Hedgire SS(2008)The template of the primary lymphatic landing sites of the prostate should be revisited: results of a multimodality mapping study Eur Urol 63 450-458
- [4] Harisinghani MG(2013)Mapping of pelvic lymph node metastases in prostate cancer Eur Urol 121 421-427
- [5] Abdollah F(2018)Identifying candidates for super-extended staging pelvic lymph node dissection among patients with high-risk prostate cancer BJU Int 72 84-109
- [6] Karnes RJ(2017)The Benefits and harms of different extents of lymph node dissection during radical prostatectomy for prostate cancer: a systematic review Eur Urol 4 665-668
- [7] Suardi N(2018)Comprehensive assessment of indocyanine green usage: one tracer, multiple urological applications Eur Urol Focus 61 540-545
- [8] Mattei A(2020)Prostate-specific membrane antigen PET/CT combined with sentinel node biopsy for primary lymph node staging in prostate cancer J Nucl Med 71 462-475
- [9] Fuechsel FG(2017)Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer Eur Urol 22 3150-3156
- [10] Bhatta Dhar N(2015)FDG PET-CT for lymph node staging of bladder cancer: a prospective study of patients with extended pelvic lymphadenectomy Ann Surg Oncol 210 W95-W109